Literature DB >> 1797302

Renovascular hypertension impairs formation of endothelium-derived relaxing factors and sensitivity to endothelin-1 in resistance arteries.

Y Dohi1, L Criscione, T F Lüscher.   

Abstract

1. Endothelium-dependent vascular regulation was investigated in mesenteric resistance arteries of Goldblatt two kidney-one clip (2K1C) renovascular hypertensive rats. 2. Third order branches of mesenteric arteries were dissected free and mounted on glass cannulae in an organ chamber. Changes in vascular diameter were measured in pressurized and perfused arteries with a video dimension analyzer. 3. Acetylcholine evoked endothelium-dependent relaxations that were much more pronounced with intraluminal than with extraluminal application. In 2K1C rats the relaxation induced by intraluminal, but not extraluminal acetylcholine was decreased compared to normotensive Wistar Kyoto rats (WKY). Increased duration of hypertension further decreased the response to intraluminal but not extraluminal acetylcholine. 4. Endothelin-1 and noradrenaline caused contractions which were augmented by removal of the endothelium. This augmentation was reduced in 2K1C rats compared to WKY; the difference was small with noradrenaline but more pronounced with endothelin-1. 5. In arteries without endothelium the sensitivity, but not the maximal contraction to endothelin-1 was lower in 2K1C rats, while the response to noradrenaline was not different in 2K1C rats and WKY. The sensitivity to the peptide was not further affected by increasing the duration of hypertension. 6. Thus, renovascular hypertension leads to an impaired intraluminal, but not extraluminal activation of the release of endothelium-derived relaxing factor and a decreased inhibitory effect of the endothelium against endothelin-1- and noradrenaline-induced contractions in mesenteric resistance arteries. Furthermore, the sensitivity, but not the maximal response of vascular smooth muscle to endothelin-1 was reduced.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797302      PMCID: PMC1908557          DOI: 10.1111/j.1476-5381.1991.tb12434.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Increased plasma endothelin level in patients with essential hypertension.

Authors:  Y Saito; K Nakao; M Mukoyama; H Imura
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

2.  Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway.

Authors:  D Diederich; Z H Yang; F R Bühler; T F Lüscher
Journal:  Am J Physiol       Date:  1990-02

3.  Down-regulation of endothelin binding sites in rat vascular smooth muscle cells.

Authors:  P Roubert; V Gillard; P Plas; P E Chabrier; P Braquet
Journal:  Am J Hypertens       Date:  1990-04       Impact factor: 2.689

4.  Reactivity and sensitivity of mesenteric vascular beds and aortic rings of spontaneously hypertensive rats to endothelin: effects of calcium entry blockers.

Authors:  L Criscione; P Nellis; B Riniker; H Thomann; R Burdet
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

5.  Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system.

Authors:  W Halpern; G Osol; G S Coy
Journal:  Ann Biomed Eng       Date:  1984       Impact factor: 3.934

6.  Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats.

Authors:  N Suzuki; T Miyauchi; Y Tomobe; H Matsumoto; K Goto; T Masaki; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

7.  Plasma immunoreactive endothelin in essential hypertension.

Authors:  M Kohno; K Yasunari; K Murakawa; K Yokokawa; T Horio; T Fukui; T Takeda
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

8.  Plasma endothelin levels in hypertension and chronic renal failure.

Authors:  M Shichiri; Y Hirata; K Ando; T Emori; K Ohta; S Kimoto; M Ogura; A Inoue; F Marumo
Journal:  Hypertension       Date:  1990-05       Impact factor: 10.190

9.  Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension.

Authors:  Y Dohi; M A Thiel; F R Bühler; T F Lüscher
Journal:  Hypertension       Date:  1990-08       Impact factor: 10.190

10.  Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells.

Authors:  T Emori; Y Hirata; K Ohta; M Shichiri; F Marumo
Journal:  Biochem Biophys Res Commun       Date:  1989-04-14       Impact factor: 3.575

View more
  6 in total

1.  Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats.

Authors:  Xiao Yu Tian; Wing Tak Wong; Fung Ping Leung; Yang Zhang; Yi-Xiang Wang; Hung Kay Lee; Chi Fai Ng; Zhen Yu Chen; Xiaoqiang Yao; Chak Leung Au; Chi Wai Lau; Paul M Vanhoutte; John P Cooke; Yu Huang
Journal:  Antioxid Redox Signal       Date:  2011-12-02       Impact factor: 8.401

Review 2.  Vasopeptidase inhibition and endothelial function in hypertension.

Authors:  L V d'Uscio; T F Lüscher
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

3.  Changes in the vascular beta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats.

Authors:  Glaucia E Callera; Ester Yeh; Rita C A Tostes; Luciana C Caperuto; Carla R O Carvalho; Lusiane M Bendhack
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

4.  Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.

Authors:  W G Haynes; M F Hand; H A Johnstone; P L Padfield; D J Webb
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  Investigation of the 5-hydroxytryptamine receptor mediating the 'maintained' short-circuit current response in guinea-pig ileal mucosa.

Authors:  C M Scott; K T Bunce; C F Spraggs
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

6.  Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension.

Authors:  Ananda T Dias; Amanda S Cintra; Jéssica C Frossard; Zaira Palomino; Dulce E Casarini; Isabele B S Gomes; Camille M Balarini; Agata L Gava; Bianca P Campagnaro; Thiago M C Pereira; Silvana S Meyrelles; Elisardo C Vasquez
Journal:  J Transl Med       Date:  2014-09-16       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.